Akiko Kimura

ORCID

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Venues

International journal of clinical oncology

Hepatology research : the official journal of the Japan Society of Hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Noboru Nakaigawa, Yoshihiko Tomita, Satoshi Tamada, Katsunori Tatsugami, Takahiro Osawa, Mototsugu Oya, Hiroomi Kanayama, Yuji Miura, Naoto Sassa, Kazuo Nishimura, Masahiro Nozawa, Naoya Masumori, Yasuhide Miyoshi, Shingo Kuroda, Akiko Kimura
Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma. International journal of clinical oncology (2023)
Noboru Nakaigawa, Yoshihiko Tomita, Satoshi Tamada, Katsunori Tatsugami, Takahiro Osawa, Mototsugu Oya, Hiroomi Kanayama, Yuji Miura, Naoto Sassa, Kazuo Nishimura, Masahiro Nozawa, Naoya Masumori, Yasuhide Miyoshi, Shingo Kuroda, Akiko Kimura
Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma. International journal of clinical oncology 28 (3) (2023)
Naoya Kato, Masatoshi Kudo, Kaoru Tsuchiya, Atsushi Hagihara, Kazushi Numata, Hiroshi Aikata, Yoshitaka Inaba, Shunsuke Kondo, Kenta Motomura, Naohiro Okano, Masafumi Ikeda, Manabu Morimoto, Shingo Kuroda, Akiko Kimura
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study. Hepatology research : the official journal of the Japan Society of Hepatology (2023)
Noboru Nakaigawa, Yoshihiko Tomita, Satoshi Tamada, Katsunori Tatsugami, Takahiro Osawa, Mototsugu Oya, Hiroomi Kanayama, Yuji Miura, Naoto Sassa, Kazuo Nishimura, Masahiro Nozawa, Naoya Masumori, Yasuhide Miyoshi, Shingo Kuroda, Akiko Kimura
Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma. International journal of clinical oncology 28 (3) (2023)
Noboru Nakaigawa, Yoshihiko Tomita, Satoshi Tamada, Katsunori Tatsugami, Takahiro Osawa, Mototsugu Oya, Hiroomi Kanayama, Yuji Miura, Naoto Sassa, Kazuo Nishimura, Masahiro Nozawa, Naoya Masumori, Yasuhide Miyoshi, Shingo Kuroda, Akiko Kimura
Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma. International journal of clinical oncology 28 (3) (2023)
Noboru Nakaigawa, Yoshihiko Tomita, Satoshi Tamada, Katsunori Tatsugami, Takahiro Osawa, Mototsugu Oya, Hiroomi Kanayama, Yuji Miura, Naoto Sassa, Kazuo Nishimura, Masahiro Nozawa, Naoya Masumori, Yasuhide Miyoshi, Shingo Kuroda, Akiko Kimura
Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma. International journal of clinical oncology 28 (3) (2023)

Akiko Kimura.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Akiko Kimura